Quick Answer
Corbus Pharmaceuticals Holdings, Inc. reported Total Assets of $168.20 million for the year ending 2025.
- Corbus Pharmaceuticals Holdings, Inc. showed an increase of +7.9% in Total Assets from 2024 to 2025.
- This data is from Corbus Pharmaceuticals Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2014: $7.63 million | Q1 2015: $5.25 million | Q2 2015: $9.56 million | Q3 2015: $13.33 million | Q1 2016: $10.50 million | Q2 2016: $22.63 million | Q3 2016: $19.76 million | Q1 2017: $50.61 million | Q2 2017: $44.56 million | Q3 2017: $38.42 million | Q1 2018: $77.14 million | Q2 2018: $70.29 million | Q3 2018: $61.18 million | Q1 2019: $101.39 million | Q2 2019: $84.12 million | Q3 2019: $68.13 million | Q1 2020: $65.20 million | Q2 2020: $98.12 million | Q3 2020: $95.84 million | Q1 2021: $140.15 million | Q2 2021: $120.61 million | Q3 2021: $119.57 million | Q1 2022: $95.68 million | Q2 2022: $82.07 million | Q3 2022: $73.83 million | Q1 2023: $51.65 million | Q2 2023: $43.72 million | Q3 2023: $36.28 million | Q1 2024: $125.74 million | Q2 2024: $151.98 million | Q3 2024: $164.17 million | Q1 2025: $139.93 million | Q2 2025: $125.09 million | Q3 2025: $109.51 million.
- Over the full 13 years of available data (2013 to 2025), Corbus Pharmaceuticals Holdings, Inc.'s Total Assets has grown by 54,952.0%.
- Historical annual values: Fiscal year 2025: $168.20 million | Fiscal year 2024: $155.88 million | Fiscal year 2023: $28.27 million | Fiscal year 2022: $66.31 million | Fiscal year 2021: $107.73 million | Fiscal year 2020: $102.29 million | Fiscal year 2019: $49.14 million | Fiscal year 2018: $46.99 million | Fiscal year 2017: $66.98 million | Fiscal year 2016: $17.89 million | Fiscal year 2015: $12.88 million | Fiscal year 2014: $6.60 million | Fiscal year 2013: $305.5 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: